🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the Efficacy and Safety of different doses of PEG-rh...
Status
Unknown
Location
Cancer Institute and Hospital, CAMS
Start Date
2013-07
Trial ID
NCT01918241
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This is a single or up to 2 centers, double-blind, randomized, single-dose,...
Status
Completed
Location
WCCT Global Inc.
Start Date
2017-02-13
Trial ID
NCT03206229
Treatments Being Tested
Purpose of the study is to investigate the safety, immunogenicity and the e...
Status
Terminated
Location
Medizinischen Hochschule (MHH) Hannover
Start Date
2011-07
Trial ID
NCT01859637
Treatments Being Tested
The purpose of this study is to assess the efficacy of selumetinib in combi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2013-09-25
Trial ID
NCT01933932
Treatments Being Tested
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-05-08
Trial ID
NCT06738368
To learn if cyclophosphamide, vincristine, and dexamethasone (called mini h...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-14
Trial ID
NCT05645718
RATIONALE: Drugs used in chemotherapy such as paclitaxel, fluorouracil, and...
Status
Completed
Location
Providence Saint Joseph Medical Center - Burbank
Start Date
2003-09
Trial ID
NCT00069953
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of ruxoliti...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-12-16
Trial ID
NCT07278856
Treatments Being Tested
This is a three-arm, 1:1:1 randomized, placebo controlled, double- blinded ...
Status
Completed
Location
University of California - San Francisco
Start Date
2014-12
Trial ID
NCT02215200